Cargando…

The use of the normal tissue non-complication probability (NTCP0) methodology as a new alternative of assessing side-effects in brachytherapy treatments

BACKGROUND: The NTCP methodology evaluating side-effects (S-Es) was initially used in radiotherapy (RT), and later was extended to brachytherapy (BT). The NTCP0 methodology has been recently introduced in RT. Given the advantages, this methodology could replace NTCP. MATERIALS AND METHODS: Revisions...

Descripción completa

Detalles Bibliográficos
Autores principales: Frometa-Castillo, Terman, Pyakuryal, Anil, Narayanasamy, Ganesh, Mesbahi, Asghar, Wals-Zurita, Amadeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521694/
https://www.ncbi.nlm.nih.gov/pubmed/36196423
http://dx.doi.org/10.5603/RPOR.a2022.0063
_version_ 1784799897025773568
author Frometa-Castillo, Terman
Pyakuryal, Anil
Narayanasamy, Ganesh
Mesbahi, Asghar
Wals-Zurita, Amadeo
author_facet Frometa-Castillo, Terman
Pyakuryal, Anil
Narayanasamy, Ganesh
Mesbahi, Asghar
Wals-Zurita, Amadeo
author_sort Frometa-Castillo, Terman
collection PubMed
description BACKGROUND: The NTCP methodology evaluating side-effects (S-Es) was initially used in radiotherapy (RT), and later was extended to brachytherapy (BT). The NTCP0 methodology has been recently introduced in RT. Given the advantages, this methodology could replace NTCP. MATERIALS AND METHODS: Revisions of studies related to use of NTCP in the evaluations of S-Es in BT. Development of the first versions of two Matlab applications of the NTCP0 methodology. These applications have three options. Two of them employ the well-known aspects of a phenomenological model, or the probabilistic relationship between NTCP0 and total NTCP (TNTCP) that is the sum(NTCP(x(i))) i: i(th) complication i:1..nc: Number of complications; where NTCP0 = 100% — TNTCP; and the third option assumes a NTCP(x(i)) discrete probabilistic distribution generated by the binomial distribution, where one of its parameters is automatically obtained from a databased of the Disease locations Vs. Late complications. RESULTS: The NTCP0cal and NTCP0calDr Matlab applications have been developed, and respectively used for fractional continuous low dose-rate BT. CONCLUSIONS: NTCP0 is defined as the ratio of the number of patients without acute/late complications and total of them, and also can be obtained using our Matlab applications. NTCP0 works do not disregard the last 10–15 years of NTCP research; but NTCP0 was not considered during these years. A generic example was used for showing the variations of the late complications and NTCP0 for a BT treatment of a constant number of fractions and six different dose per fraction values.
format Online
Article
Text
id pubmed-9521694
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Via Medica
record_format MEDLINE/PubMed
spelling pubmed-95216942022-10-03 The use of the normal tissue non-complication probability (NTCP0) methodology as a new alternative of assessing side-effects in brachytherapy treatments Frometa-Castillo, Terman Pyakuryal, Anil Narayanasamy, Ganesh Mesbahi, Asghar Wals-Zurita, Amadeo Rep Pract Oncol Radiother Research Paper BACKGROUND: The NTCP methodology evaluating side-effects (S-Es) was initially used in radiotherapy (RT), and later was extended to brachytherapy (BT). The NTCP0 methodology has been recently introduced in RT. Given the advantages, this methodology could replace NTCP. MATERIALS AND METHODS: Revisions of studies related to use of NTCP in the evaluations of S-Es in BT. Development of the first versions of two Matlab applications of the NTCP0 methodology. These applications have three options. Two of them employ the well-known aspects of a phenomenological model, or the probabilistic relationship between NTCP0 and total NTCP (TNTCP) that is the sum(NTCP(x(i))) i: i(th) complication i:1..nc: Number of complications; where NTCP0 = 100% — TNTCP; and the third option assumes a NTCP(x(i)) discrete probabilistic distribution generated by the binomial distribution, where one of its parameters is automatically obtained from a databased of the Disease locations Vs. Late complications. RESULTS: The NTCP0cal and NTCP0calDr Matlab applications have been developed, and respectively used for fractional continuous low dose-rate BT. CONCLUSIONS: NTCP0 is defined as the ratio of the number of patients without acute/late complications and total of them, and also can be obtained using our Matlab applications. NTCP0 works do not disregard the last 10–15 years of NTCP research; but NTCP0 was not considered during these years. A generic example was used for showing the variations of the late complications and NTCP0 for a BT treatment of a constant number of fractions and six different dose per fraction values. Via Medica 2022-09-19 /pmc/articles/PMC9521694/ /pubmed/36196423 http://dx.doi.org/10.5603/RPOR.a2022.0063 Text en © 2022 Greater Poland Cancer Centre https://creativecommons.org/licenses/by-nc-nd/4.0/This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially
spellingShingle Research Paper
Frometa-Castillo, Terman
Pyakuryal, Anil
Narayanasamy, Ganesh
Mesbahi, Asghar
Wals-Zurita, Amadeo
The use of the normal tissue non-complication probability (NTCP0) methodology as a new alternative of assessing side-effects in brachytherapy treatments
title The use of the normal tissue non-complication probability (NTCP0) methodology as a new alternative of assessing side-effects in brachytherapy treatments
title_full The use of the normal tissue non-complication probability (NTCP0) methodology as a new alternative of assessing side-effects in brachytherapy treatments
title_fullStr The use of the normal tissue non-complication probability (NTCP0) methodology as a new alternative of assessing side-effects in brachytherapy treatments
title_full_unstemmed The use of the normal tissue non-complication probability (NTCP0) methodology as a new alternative of assessing side-effects in brachytherapy treatments
title_short The use of the normal tissue non-complication probability (NTCP0) methodology as a new alternative of assessing side-effects in brachytherapy treatments
title_sort use of the normal tissue non-complication probability (ntcp0) methodology as a new alternative of assessing side-effects in brachytherapy treatments
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521694/
https://www.ncbi.nlm.nih.gov/pubmed/36196423
http://dx.doi.org/10.5603/RPOR.a2022.0063
work_keys_str_mv AT frometacastilloterman theuseofthenormaltissuenoncomplicationprobabilityntcp0methodologyasanewalternativeofassessingsideeffectsinbrachytherapytreatments
AT pyakuryalanil theuseofthenormaltissuenoncomplicationprobabilityntcp0methodologyasanewalternativeofassessingsideeffectsinbrachytherapytreatments
AT narayanasamyganesh theuseofthenormaltissuenoncomplicationprobabilityntcp0methodologyasanewalternativeofassessingsideeffectsinbrachytherapytreatments
AT mesbahiasghar theuseofthenormaltissuenoncomplicationprobabilityntcp0methodologyasanewalternativeofassessingsideeffectsinbrachytherapytreatments
AT walszuritaamadeo theuseofthenormaltissuenoncomplicationprobabilityntcp0methodologyasanewalternativeofassessingsideeffectsinbrachytherapytreatments
AT frometacastilloterman useofthenormaltissuenoncomplicationprobabilityntcp0methodologyasanewalternativeofassessingsideeffectsinbrachytherapytreatments
AT pyakuryalanil useofthenormaltissuenoncomplicationprobabilityntcp0methodologyasanewalternativeofassessingsideeffectsinbrachytherapytreatments
AT narayanasamyganesh useofthenormaltissuenoncomplicationprobabilityntcp0methodologyasanewalternativeofassessingsideeffectsinbrachytherapytreatments
AT mesbahiasghar useofthenormaltissuenoncomplicationprobabilityntcp0methodologyasanewalternativeofassessingsideeffectsinbrachytherapytreatments
AT walszuritaamadeo useofthenormaltissuenoncomplicationprobabilityntcp0methodologyasanewalternativeofassessingsideeffectsinbrachytherapytreatments